TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -1 | -2 | 16 | 44 | 56 | 27 | 23 |
| P | %wins | 50 | 50 | 100 | 100 | 100 | 50 | 75 | |||
| S | %ret | 1 | 1 | 1 | -1 | -5 | -15 | 5 | -7 | 0 | -5 |
| S | %wins | 100 | 100 | 100 | 0 | 100 | 80 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/8/19 16:19 | 4/8/19 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Shorrer Doron | L3 | D | P.d | 10 | 0.7000 | 0 | 14 | 2 | 897 | D | |||||||||||||||
6/6/16 16:01 | 5/30/16 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Shorrer Doron | L3 | D | S | -19 | 1.52 | 0 | -12 | -2 | 570 | I | -53 | -44 | 10 | 15 | -11 | -1 | -1 | 1 | -1 | -5 | -15 | 5 | -7 | ||
2/17/16 16:00 | 2/15/16 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Shorrer Doron | L3 | D | P | 10 | 0.8074 | 0 | 12 | 2 | 583 | I | -74 | -64 | -52 | -31 | -6 | 22 | 20 | 33 | 0 | 0 | 20 | 27 | 29 | -17 | |
12/7/10 14:34 | 12/7/10 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Shorrer Doron | L3 | D | P | 10 | 1.40 | 0 | 7 | 4 | 169 | D | 251 | 34 | 45 | 37 | -6 | 10 | 13 | 9 | -1 | -4 | 12 | 60 | 83 | 70 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |